# Avalo Therapeutics, Inc. (AVTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AVTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 60.4K | $ -80.13M | $ -136.36M | $ 2.43M | $ 83.05M |
| 2024 | $ 463.5K | $ -36.92M | $ -51.19M | $ 568.0K | $ 133.03M |
| 2023 | $ 2.08M | $ -34.11M | $ -33.32M | $ 537.0K | $ 7.30M |
| 2022 | $ 20.16M | $ -46.54M | $ -30.05M | $ 19.95M | $ -10.92M |
| 2021 | $ 6.42M | $ -100.29M | $ -84.40M | $ 33.32M | $ 23.08M |
| 2020 | $ 8.54M | $ -80.89M | $ -37.46M | $ 426.0K | $ 24.56M |
| 2019 | $ 8.71M | $ -20.75M | $ -25.27M | $ 155.8K | $ 21.00M |
| 2018 | $ 24.20M | $ -52.90M | $ -2.99M | $ 15.38M | $ 20.91M |
| 2017 | $ 37.47M | $ 15.99M | $ -8.61M | $ 0 | $ 27.86M |
| 2016 | $ 1.59M | $ -22.66M | $ -20.10M | $ 2.35M | $ 207.0K |
| 2015 | $ 0 | $ -14.73M | $ -42.36M | $ 5.56M | $ 13.08M |
| 2014 | $ 0 | $ -22.69M | $ -21.96M | $ 7.21M | $ -26.33M |
| 2013 | $ 20.07M | $ -4.37M | $ -3.16M | $ 0 | $ 2.01M |
| 2012 | $ 0 | $ -3.65M | $ -3.98M | $ 0 | $ 8.48M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.40 |
| Current Ratio | 8.14 |

## Other views

- [Metrics](https://sponda.capital/en/AVTX.md)
- [Charts](https://sponda.capital/en/AVTX/charts.md)
- [Compare](https://sponda.capital/en/AVTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.